Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ROSSARI BIOTECH LIMITED Call Transcript 2020

Aug 20, 2020

59144_rns_2020-08-20_db2536d4-c3fc-4aaa-9dfe-7826bc2de307.pdf

Call Transcript

Open in viewer

Opens in your device viewer

August 20, 2020

DCS-CRD Listing Compliance
BSE Limited National Stock Exchange of India Ltd.
First Floor, New Trade Wing Exchange Plaza, 5th Floor
Rotunda Building, Plot N o.C/1, 'G'Block
Phiroze Jeejeebhoy Towers Bandra- Kurla Complex
Dalal Street, Fort Sandra East
Mumbai 400 023 Mumbai 400 051
Fax No.2272 3121/2037 /2039 Fax No.2659 8237 /8238
Stock Code: 543213 Stock Code: ROSSARI

Dear Sir/Madam,

Sub: Update on Intimation of conference call for investors and analysts under Company on Monday, August 24, 2020.

Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our letter dated August 19, 2020, regarding conference call for investors and analysts, we hereby would like to update that the conference call for investors and analysts will be on Monday, August 24, 2020 at 05:00 P.M.

The conference call will be initiated with a brief management discussion on the results for quarter ended June 30, 2019 followed by an interactive Question & Answer session.

Invite in this regard is attached for your information and record.

The same may please be taken on record and suitably disseminated to all concerned.

Thanking you,

Yours Sincerely, For Rossari Biotech Limited

Parul Gupta Company Secretary & Compliance Officer Membership No.: A38895

ROSSARI BIOTECH LIMITED (An ISO 9001 :2015 & 14001 :2015 Certified Company)

Regd. Office : 201 A & B, Ackruti Corporate Park, Next to GE Gardens, LBS Marg, Kanjurmarg (W). Mumbai - 400078. India. T +91-22-6123 3800 F +91-22-2579 6982 factory: Plot No. 10 & 11, Survey No. 90/1/10 & 90/1/111/1, Kumbharwadi, Village Naroli, Dadra & Nagar Haveli (U.T.), Silvassa - 396 235. India. T 0260 - 669 3000 E [email protected] W www.rossari.com CIN: U24100MH2009PLC194818

Axis House, C-2, Wadia International Centre, P.B Marg. Worli, Mumbai 400 025 (India)

Rossari Biotech Ltd

Q1FY21 Earnings Call on August 24th 2020 hosted by Axis Capital Limited

We are pleased to host post results earnings conference call for analysts and investors, on Monday, August 24th 2020 at 5:00 pm, on behalf of Rossari Biotech Ltd, following the announcement of financial results for the quarter ended 30th June 2020.

The call will be initiated with a brief management discussion on the Q1FY21 earnings performance followed by an interactive Question & Answer session. The management team will be represented by

  • Mr. Edward Menezes, Promoter & Executive Chairman
  • Mr. Sunil Chari, Promoter & Managing Director
  • Ms. Manasi Nisal, Chief Financial Officer

Details of the conference call are:

Date : Monday, 24th August, 2020
Time : 5:00 PM IST 7:30 PM HK/SG 12:30 PM UK 7:30 AM US (ET)
Call Leader : Ankur Periwal, Axis Capital Ltd
Country Dial in numbers
Primary number +91 22 6280 1145
Secondary number +91 22 7115 8046
India Local +91 70456 71221
International Dial In
- Hong Kong 800 964 448
- Singapore 800 101 2045
- U K 0 808 101 1573
- USA 1 866 746 2133

Or please use the under mentioned Diamond Pass link to pre-register for the earnings call and avoid queue: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6819154&linkSecurityString=124 6aef21e

For further information please contact

Ankur Periwal, CFA, FRM

SVP – Specialty Chemicals & Midcaps Axis Capital Limited Direct: +91 22 4325 1118 Mobile: +91 98204 16359 Email: [email protected]